Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PFE
PFE logo

PFE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PFE News

Viking Therapeutics: A Dark Horse in the GLP-1 Market

1d agoFool

Viking Therapeutics' VK2735: A Dark Horse in GLP-1 Weight Loss Market

1d agoNASDAQ.COM

Viking Therapeutics: A Dark Horse in the GLP-1 Market

1d agoYahoo Finance

Salesforce Stock Decline Amid Strong Performance Metrics

1d agoFool

Salesforce's Profitability Nears All-Time High

1d agoNASDAQ.COM

EMA's CHMP Suggests Expanding Therapeutic Use for Hympavzi

2d agomoomoo

SHIONOGI ANNOUNCES 300 BILLION YEN BRIDGE LOAN AGREEMENT FOR FURTHER INVESTMENT IN VIIV HEALTHCARE

2d agomoomoo

Eli Lilly's GLP-1 Drug Sales Surge Impressively

3d agoFool

Eli Lilly's GLP-1 Drug Sales Surge Significantly

3d agoNASDAQ.COM

Merck's Acquisition Sparks Interest in Blood Cancer Drug Market

4d agostocktwits

SLS Shares Surge Following Merck's Tern Acquisition, Fueling Buyout Speculation in Blood Cancer Sector: Retail Investors Eye Major Pharma Contender

4d agostocktwits

22 S&P 500 Stocks Offering Over 5% Yield: 6 Recommended for Purchase.

4d agoBarron's

Pfizer's Clinical Trial Results Spark Market Interest

4d agoFool

Pfizer Achieves Progress in Phase 2 Clinical Trial

4d agoNASDAQ.COM

Trump Administration Delays Nomination for CDC Director

4d agoseekingalpha

PFIZER: GUGGENHEIM INCREASES TARGET PRICE TO $36, UP FROM $35

5d agomoomoo